Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Tobacco Use 1Tobacco Smoking 1Testicular Neoplasms 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Health Behavior 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × Costs and Cost Analysis × Clear all
NCT04531709 2025-07-14

Financial Toxicity and Quality of Life in Patients With TGCT

The University of Texas Health Science Center at San Antonio

Completed
24 enrolled
Genitourinary

Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡